HEADER TRANSFERASE 17-MAR-10 2X9E TITLE HUMAN MPS1 IN COMPLEX WITH NMS-P715 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN 514-828; COMPND 5 SYNONYM: MPS1, PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVLGSTG KEYWDS KINASE, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TYROSINE- KEYWDS 2 PROTEIN KINASE, MITOTIC CHECKPOINT EXPDTA X-RAY DIFFRACTION AUTHOR R.COLOMBO,M.CALDARELLI,M.MENNECOZZI,M.L.GIORGINI,F.SOLA,P.CAPPELLA, AUTHOR 2 C.PERRERA,S.R.DEPAOLINI,L.RUSCONI,U.CUCCHI,N.AVANZI,J.A.BERTRAND, AUTHOR 3 R.T.BOSSI,E.PESENTI,A.GALVANI,A.ISACCHI,F.COLOTTA,D.DONATI,J.MOLL REVDAT 3 20-DEC-23 2X9E 1 REMARK REVDAT 2 27-MAR-19 2X9E 1 SOURCE REVDAT 1 29-DEC-10 2X9E 0 JRNL AUTH R.COLOMBO,M.CALDARELLI,M.MENNECOZZI,M.L.GIORGINI,F.SOLA, JRNL AUTH 2 P.CAPPELLA,C.PERRERA,S.R.DEPAOLINI,L.RUSCONI,U.CUCCHI, JRNL AUTH 3 N.AVANZI,J.A.BERTRAND,R.T.BOSSI,E.PESENTI,A.GALVANI, JRNL AUTH 4 A.ISACCHI,F.COLOTTA,D.DONATI,J.MOLL JRNL TITL TARGETING THE MITOTIC CHECKPOINT FOR CANCER THERAPY WITH JRNL TITL 2 NMS-P715, AN INHIBITOR OF MPS1 KINASE. JRNL REF CANCER RES. V. 70 10255 2010 JRNL REFN ISSN 0008-5472 JRNL PMID 21159646 JRNL DOI 10.1158/0008-5472.CAN-10-2101 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1573647.320 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.8 REMARK 3 NUMBER OF REFLECTIONS : 7416 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.306 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 388 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.016 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.29 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 818 REMARK 3 BIN R VALUE (WORKING SET) : 0.3490 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 51 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.047 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2068 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -16.79000 REMARK 3 B22 (A**2) : 32.58000 REMARK 3 B33 (A**2) : -15.78000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM SIGMAA (A) : 0.60 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.52 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.51 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.480 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.670 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.940 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.290 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 35.08 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : 715.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : 715.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2X9E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1290043300. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07230 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7419 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 56.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3CEK REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 20000, 0.1 M MES PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.24250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.24250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 52.83250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.68100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 52.83250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.68100 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 36.24250 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 52.83250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 56.68100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 36.24250 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 52.83250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 56.68100 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 512 REMARK 465 PRO A 513 REMARK 465 ALA A 514 REMARK 465 GLN A 670 REMARK 465 MET A 671 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 GLN A 683 REMARK 465 VAL A 684 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 465 MET A 809 REMARK 465 LYS A 810 REMARK 465 TYR A 811 REMARK 465 VAL A 812 REMARK 465 LEU A 813 REMARK 465 GLY A 814 REMARK 465 GLN A 815 REMARK 465 LEU A 816 REMARK 465 VAL A 817 REMARK 465 GLY A 818 REMARK 465 LEU A 819 REMARK 465 ASN A 820 REMARK 465 SER A 821 REMARK 465 PRO A 822 REMARK 465 ASN A 823 REMARK 465 SER A 824 REMARK 465 ILE A 825 REMARK 465 LEU A 826 REMARK 465 LYS A 827 REMARK 465 ALA A 828 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 795 CA C O CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 531 -76.94 -112.74 REMARK 500 SER A 536 34.19 -84.83 REMARK 500 GLU A 545 -76.86 -47.28 REMARK 500 LYS A 546 29.77 -57.43 REMARK 500 LEU A 557 60.39 -115.08 REMARK 500 GLN A 563 -75.16 -56.07 REMARK 500 LEU A 578 14.56 -68.85 REMARK 500 GLN A 580 31.17 -85.52 REMARK 500 GLN A 640 20.84 -75.05 REMARK 500 HIS A 641 27.86 -146.48 REMARK 500 SER A 646 -10.51 69.68 REMARK 500 LYS A 696 14.24 -64.69 REMARK 500 TRP A 718 -77.56 -36.76 REMARK 500 THR A 728 -62.03 -109.84 REMARK 500 ASP A 763 -72.62 -48.61 REMARK 500 GLN A 794 -33.67 -178.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 793 GLN A 794 130.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SVE A 1796 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HMO RELATED DB: PDB REMARK 900 CTCEL116: A CELLULASE FROM CLOSTRIDIUM THERMOCELLUM REMARK 900 RELATED ID: 3HMP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN IONOTROPIC GLUTAMATE RECEPTOR GLUR2 REMARK 900 ATD REGION AT 1.8A RESOLUTION REMARK 900 RELATED ID: 3H9F RELATED DB: PDB REMARK 900 THE FOLDING MECHANISM OF BBL: PLASTICITY OF TRANSITION-STATE REMARK 900 STRUCTURE OBSERVED WITHIN AN ULTRAFAST FOLDING PROTEIN FAMILY. REMARK 900 RELATED ID: 3HMN RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN NEISSERIA MENINGITIDIS FACTOR H REMARK 900 BINDING PROTEIN AND CCPS 6-7 OF HUMAN COMPLEMENT FACTOR H REMARK 900 RELATED ID: 3GFW RELATED DB: PDB REMARK 900 PERIPLASMIC DOMAIN OF EPSL FROM VIBRIO PARAHAEMOLYTICUS REMARK 900 RELATED ID: 2ZMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANB IN COMPLEX WITH REMARK 900 2,7-ANHYDRO-NEU5AC REMARK 900 RELATED ID: 3CEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ACYL-ENZYME OXA-10 K70C-AMPICILLIN AT PH 7 REMARK 900 RELATED ID: 2ZMD RELATED DB: PDB REMARK 900 ALPHA-GLUCAN BINDING BY A STREPTOCOCCAL VIRULENCE FACTOR REMARK 900 RELATED ID: 3DBQ RELATED DB: PDB REMARK 900 RNASE A-NADP COMPLEX DBREF 2X9E A 514 828 UNP P33981 TTK_HUMAN 514 828 SEQADV 2X9E GLY A 512 UNP P33981 EXPRESSION TAG SEQADV 2X9E PRO A 513 UNP P33981 EXPRESSION TAG SEQRES 1 A 317 GLY PRO ALA ASN GLU CYS ILE SER VAL LYS GLY ARG ILE SEQRES 2 A 317 TYR SER ILE LEU LYS GLN ILE GLY SER GLY GLY SER SER SEQRES 3 A 317 LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS GLN ILE TYR SEQRES 4 A 317 ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA ASP ASN GLN SEQRES 5 A 317 THR LEU ASP SER TYR ARG ASN GLU ILE ALA TYR LEU ASN SEQRES 6 A 317 LYS LEU GLN GLN HIS SER ASP LYS ILE ILE ARG LEU TYR SEQRES 7 A 317 ASP TYR GLU ILE THR ASP GLN TYR ILE TYR MET VAL MET SEQRES 8 A 317 GLU CYS GLY ASN ILE ASP LEU ASN SER TRP LEU LYS LYS SEQRES 9 A 317 LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SER TYR TRP SEQRES 10 A 317 LYS ASN MET LEU GLU ALA VAL HIS THR ILE HIS GLN HIS SEQRES 11 A 317 GLY ILE VAL HIS SER ASP LEU LYS PRO ALA ASN PHE LEU SEQRES 12 A 317 ILE VAL ASP GLY MET LEU LYS LEU ILE ASP PHE GLY ILE SEQRES 13 A 317 ALA ASN GLN MET GLN PRO ASP THR THR SER VAL VAL LYS SEQRES 14 A 317 ASP SER GLN VAL GLY THR VAL ASN TYR MET PRO PRO GLU SEQRES 15 A 317 ALA ILE LYS ASP MET SER SER SER ARG GLU ASN GLY LYS SEQRES 16 A 317 SER LYS SER LYS ILE SER PRO LYS SER ASP VAL TRP SER SEQRES 17 A 317 LEU GLY CYS ILE LEU TYR TYR MET THR TYR GLY LYS THR SEQRES 18 A 317 PRO PHE GLN GLN ILE ILE ASN GLN ILE SER LYS LEU HIS SEQRES 19 A 317 ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU PHE PRO ASP SEQRES 20 A 317 ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU LYS CYS CYS SEQRES 21 A 317 LEU LYS ARG ASP PRO LYS GLN ARG ILE SER ILE PRO GLU SEQRES 22 A 317 LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN THR HIS PRO SEQRES 23 A 317 VAL ASN GLN MET ALA LYS GLY THR THR GLU GLU MET LYS SEQRES 24 A 317 TYR VAL LEU GLY GLN LEU VAL GLY LEU ASN SER PRO ASN SEQRES 25 A 317 SER ILE LEU LYS ALA HET SVE A1796 49 HETNAM SVE N-(2,6-DIETHYLPHENYL)-1-METHYL-8-({4-[(1- HETNAM 2 SVE METHYLPIPERIDIN-4-YL)CARBAMOYL]-2-(TRIFLUOROMETHOXY) HETNAM 3 SVE PHENYL}AMINO)-4,5-DIHYDRO-1H-PYRAZOLO[4,3- HETNAM 4 SVE H]QUINAZOLINE-3-CARBOXAMIDE FORMUL 2 SVE C35 H39 F3 N8 O3 FORMUL 3 HOH *2(H2 O) HELIX 1 1 ASP A 561 LEU A 578 1 18 HELIX 2 2 GLN A 579 SER A 582 5 4 HELIX 3 3 LEU A 609 LYS A 616 1 8 HELIX 4 4 ASP A 620 GLN A 640 1 21 HELIX 5 5 LYS A 649 ALA A 651 5 3 HELIX 6 6 PRO A 691 LYS A 696 1 6 HELIX 7 7 PRO A 713 GLY A 730 1 18 HELIX 8 8 ILE A 741 ILE A 747 1 7 HELIX 9 9 GLU A 761 LEU A 772 1 12 HELIX 10 10 SER A 781 LEU A 786 1 6 HELIX 11 11 HIS A 788 ILE A 793 1 6 SHEET 1 AA 6 CYS A 517 VAL A 520 0 SHEET 2 AA 6 ARG A 523 SER A 533 -1 O ARG A 523 N VAL A 520 SHEET 3 AA 6 SER A 537 LEU A 543 -1 O VAL A 539 N ILE A 531 SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555 SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AB 3 ILE A 607 ASP A 608 0 SHEET 2 AB 3 PHE A 653 VAL A 656 -1 N ILE A 655 O ILE A 607 SHEET 3 AB 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 SITE 1 AC1 18 LYS A 529 ILE A 531 GLY A 534 SER A 537 SITE 2 AC1 18 GLN A 541 ALA A 551 LYS A 553 ILE A 586 SITE 3 AC1 18 GLU A 603 CYS A 604 GLY A 605 ASN A 606 SITE 4 AC1 18 ILE A 607 SER A 611 ASN A 652 LEU A 654 SITE 5 AC1 18 ILE A 663 ASP A 664 CRYST1 105.665 113.362 72.485 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009464 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008821 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013796 0.00000